Quick Overview: How Do We as an Industry Support Rare & Ultra-Rare Disease? ATW Opening Plenary: The Future of Cell & Gene Decentralized Manufacturing & Point of Care ATW
Advanced Therapies Week 2025 How - Detailed Overview & Context
How Do We as an Industry Support Rare & Ultra-Rare Disease? ATW Opening Plenary: The Future of Cell & Gene Decentralized Manufacturing & Point of Care ATW Considering the End Early: Planning for CGT Success from the Start ATW Two Sides of the CGT Coin: Development & The Patient Journey ATW New Market Models for Supply – Risk Mitigation, GPOs & Stability ATW
GermFree's Stephen Ondek and Sean Bartholomew talk to IBTV at Phacilitate's - Chris White, Patient, Mucosal Melanoma & TIL Kelley Lancaster - Senior Business Development Manager at Charles River talks to IBTV at Phacilitate's - Ohad Karnieli, Founder and CEO at ADVA Biotechnology talks to IBTV at the ATW Awards
